Ikarian Capital’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-143,214
| Closed | -$2.09M | – | 65 |
|
|
2022
Q2 | $2.09M | Sell |
143,214
-364,134
| -72% | -$5.32M | 0.38% | 28 |
|
|
2022
Q1 | $10.1M | Buy |
507,348
+29,930
| +6% | +$598K | 1.33% | 6 |
|
|
2021
Q4 | $8.35M | Buy |
477,418
+85,000
| +22% | +$1.49M | 1.24% | 9 |
|
|
2021
Q3 | $3.08M | Buy |
392,418
+266,874
| +213% | +$2.09M | 0.22% | 53 |
|
|
2021
Q2 | $1.29M | Sell |
125,544
-9,550
| -7% | -$98.2K | 0.1% | 103 |
|
|
2021
Q1 | $1.77M | Sell |
135,094
-39,183
| -22% | -$513K | 0.06% | 108 |
|
|
2020
Q4 | $2.45M | Sell |
174,277
-100,000
| -36% | -$1.41M | 0.11% | 65 |
|
|
2020
Q3 | $3.26M | Buy |
274,277
+66,770
| +32% | +$794K | 0.24% | 40 |
|
|
2020
Q2 | $3.12M | Buy |
+207,507
| New | +$3.12M | 0.25% | 35 |
|